|Bid||18.00 x 1400|
|Ask||18.92 x 1000|
|Day's range||18.43 - 19.98|
|52-week range||14.48 - 31.54|
|Beta (5Y monthly)||1.43|
|PE ratio (TTM)||N/A|
|Earnings date||05 Nov 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||32.33|
Theravance Bio (TBPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Theravance Biopharma, Inc. (NASDAQ:TBPH) shareholders should be happy to see the share price up 26% in the last month...
Theravance Bio (TBPH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.